Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001861948 | SCV002162524 | uncertain significance | not provided | 2022-03-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 585160). This variant has not been reported in the literature in individuals affected with MRPL44-related conditions. This variant is present in population databases (rs141821599, gnomAD 0.06%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 166 of the MRPL44 protein (p.Val166Met). |
Genome |
RCV000709982 | SCV000840348 | not provided | Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |